Skip to main content
ADPT
NASDAQ Life Sciences

Adaptive Biotechnologies Beats Q3 Revenue Estimates With $83.9M, Swings to Profit

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$28.8
Mkt Cap
$4.263B
52W Low
$12
52W High
$30.74
52W Position info
140% above low
Off High info
6.3% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ADPT has more than doubled off its 52-week low of $12.

Summary

Adaptive Biotechnologies reported Q3 revenue of $83.9 million, down 11% from a year earlier but well above the $71.6 million IBES estimate, and posted net income of $2.8 million, or $0.02 per share. Adjusted EBITDA came in at $14.3 million versus an expected loss of $495 thousand — a sharp swing past consensus. Operating expenses of $84.4 million still slightly exceeded revenue, leaving operating income at a marginal loss of $457 thousand, so the bottom line leans on non-operating items. The company raised its full-year MRD revenue outlook to $276 million–$286 million. This follows the strong Q2 print on August 5 that beat estimates and came with a raised full-year MRD revenue outlook and plans to separate the Immune Medicine business. The revenue beat and positive adjusted EBITDA support the MRD franchise story; the thin operating margin is the caveat.

At the time of this announcement, ADPT was trading at $28.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $12.00 to $30.74. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ADPT - Latest Insights

ADPT
Nov 04, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.48
Real-time Price: $27.89 info
Change: -$0.5879 (-2%) info
Market Cap: $4.521B info
ADPT
Sep 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $27.98
Real-time Price: $27.89 info
Change: -$0.0879 (-0.31%) info
Market Cap: $4.521B info
ADPT
Aug 19, 2026, 8:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $25.80
Real-time Price: $27.89 info
Change: +$2.09 (+8%) info
Market Cap: $4.521B info
ADPT
Aug 04, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.66
Real-time Price: $27.89 info
Change: +$3.23 (+13%) info
Market Cap: $4.521B info
ADPT
Jul 29, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.15
Real-time Price: $27.89 info
Change: +$5.74 (+26%) info
Market Cap: $4.521B info